Inventor · disambiguated record
Elena S. Koltun
Also filed as: KOLTUN ELENA S
39 granted patents·31 pending applications·222 citations·filing 2006–2025
97Inventor score
Files withREVOLUTION MEDICINES INC46EXELIXIS INC11VALO HEALTH INC4SFUNGA THERAPEUTICS INC2BRISTOL MYERS SQUIBB CO1
Top patents by PatentIndex Score
70 records- 0198US12465643B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Granted Nov 11, 2025·1 cites·2 claims
- 0298US11952352B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Apr 9, 2024·6 cites·4 claims
- 0398US11608346B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Mar 21, 2023·9 cites·7 claims
- 0497US11566007B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jan 31, 2023·10 cites·2 claims
- 0596US12280113B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Apr 22, 2025·2 cites·4 claims
- 0696US11739074B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Aug 29, 2023·9 cites·2 claims
- 0796US7803839B2Azetidines as MEK inhibitors for the treatment of proliferative diseasesEXELIXIS INC·Filed 2006·Granted Sep 28, 2010·46 cites·68 claims
- 0895US12202845B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Granted Jan 21, 2025·3 cites·6 claims
- 0995US11548886B2Monocyclic compounds useful as GPR120 modulatorsVALO HEALTH INC·Filed 2020·Granted Jan 10, 2023·4 cites·10 claims
- 1094US12252497B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Granted Mar 18, 2025·3 cites·10 claims
- 1194US11690915B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2021·Granted Jul 4, 2023·9 cites·2 claims
- 1294US11168102B1Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2020·Granted Nov 9, 2021·5 cites·18 claims
- 1394US10590090B22,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2018·Granted Mar 17, 2020·28 cites·50 claims
- 1494US7915250B2Azetidines as MEK inhibitors for the treatment of proliferative diseasesEXELIXIS INC·Filed 2010·Granted Mar 29, 2011·22 cites·26 claims
- 1591US8362002B2Azetidines as MEK inhibitors for the treatment of proliferative diseasesEXELIXIS INC·Filed 2011·Granted Jan 29, 2013·12 cites·63 claims
- 1689US9957290B2Derivatives of amphotericin BREVOLUTION MEDICINES INC·Filed 2016·Granted May 1, 2018·8 cites·18 claims
- 1789US2025100966A1Mek inhibitors and methods of their useEXELIXIS INC·Filed 2024·Application pending·0 cites
- 1888US2025145643A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 1987US10800773B2Monocyclic compounds useful as GPR120 modulatorsINTEGRAL HEALTH INC·Filed 2017·Granted Oct 13, 2020·5 cites·20 claims
- 2086US12384750B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Granted Aug 12, 2025·0 cites·8 claims
- 2184US10865201B2Bicyclic compounds useful as GPR120 modulatorsVALO HEALTH INC·Filed 2017·Granted Dec 15, 2020·4 cites·20 claims
- 2283US10597420B2Derivatives of amphotericin BSFUNGA THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·4 cites·20 claims
- 2383US8053454B2Pyridopyrimidinone inhibitors of PIM-1 and/or PIM-3EXELIXIS INC·Filed 2006·Granted Nov 8, 2011·4 cites·10 claims
- 2482US12409225B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Granted Sep 9, 2025·0 cites·23 claims
- 2582US12403196B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Granted Sep 2, 2025·0 cites·4 claims
- 2682US8242129B26-phenylpyrimidinones as PIM modulatorsTSUHAKO AMY L·Filed 2008·Granted Aug 14, 2012·8 cites·12 claims
- 2780US10882883B2Derivatives of amphotericin BSFUNGA THERAPEUTICS INC·Filed 2020·Granted Jan 5, 2021·1 cites·24 claims
- 2880US2025255964A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
- 2980US2025319187A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
- 3079US8440663B24-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of useMANN GRACE·Filed 2007·Granted May 14, 2013·7 cites·33 claims
- 3179US8324231B2Pyrimidinones as casein kinase II (CK2) modulatorsKOLTUN ELENA S·Filed 2008·Granted Dec 4, 2012·5 cites·10 claims
- 3279US2023106174A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Application pending·0 cites
- 3378US12116362B2Monocyclic compounds useful as GPR120 modulatorsVALO HEALTH INC·Filed 2022·Granted Oct 15, 2024·0 cites·21 claims
- 3477US11673896B2Pyridine compounds as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2019·Granted Jun 13, 2023·1 cites·16 claims
- 3576US2025074923A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 3676US2025361245A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 3775US11739093B2Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2019·Granted Aug 29, 2023·1 cites·18 claims
- 3875US10035790B2RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jul 31, 2018·3 cites·13 claims
- 3975US2025051306A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 4075US2023374035A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 4174US11597699B2MEK inhibitors and methods of their useEXELIXIS INC·Filed 2020·Granted Mar 7, 2023·0 cites·1 claims
- 4273US12258366B2Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2022·Granted Mar 25, 2025·0 cites·14 claims
- 4373US8101625B2Pyrimidinones as Casein Kinase II (CK2) modulatorsRICE KENNETH D·Filed 2006·Granted Jan 24, 2012·2 cites·13 claims
- 4471US12365688B2Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Jul 22, 2025·0 cites·36 claims
- 4571US2024139185A1Compounds that participate in cooperative binding and uses thereofREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 4670US2024067636A1Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 4770US2020031770A1Mek inhibitors and methods of their useEXELIXIS INC·Filed 2019·Application pending·0 cites
- 4870US2024101577A1Polycyclic compounds as allosteric shp2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 4970US2024092795A1Pyridine compounds as allosteric shp2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 5069US2025368661A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Elena S. Koltun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →